NEPHROS INC
No SEC Form 4 filings for $NEPH in the last 30 days.
See all $NEPH insider activity →Several biotech stocks are trading higher in premarket, including Autonomix Medical (AMIX) up 29% at $6.92, Picard Medical (PMI) up 12% at $5.85, and others. The gains indicate early momentum and potential volatility for the trading day, according to the market activity.
NEPHROS INC (NEPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202 nephros.com Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026 Record Second-Quarter Net Revenue Growth of 36% to $6 million; Core Program
Nephros, Inc. announced it will file its first-quarter 2026 financial results on Thursday, May 7, 2026, after market close and will host a conference call the same day at 4:30 PM ET. The company, a water technology provider, detailed the dial-in information for the conference call and replay access. An audio archive will be available on the Nephros Investor Relations page.
Over the past 7 days, alphai's AI scored 1 news story mentioning NEPH (NEPHROS INC). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent NEPH coverage spans financial news, market movers and earnings.
Modest pre‑market gain reflects mild optimism.
The filing provides a fresh earnings datapoint with a material one-time tariff refund that also affects gross margin and receivables.
Nephros is scheduled to release its Q1 2026 financial results on May 7, 2026, after market close, with a conference call at 4:30 PM ET. This event could lead to increased volatility in the company's stock around the release date.
Nephros' expansion into water safety consulting with ASSE 12080 certification signals strategic growth in healthcare and water management markets. The bullish sentiment and increased service offerings may positively influence stock performance in the near term.
Nephros reported a significant increase in revenue and sustained profitability, suggesting positive momentum.
alphai scores every news story that mentions NEPH with an AI model for sentiment and relevance, and aggregates insider trades from NEPHROS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Several biotech stocks are trading higher in premarket, including Autonomix Medical (AMIX) up 29% at $6.92, Picard Medical (PMI) up 12% at $5.85, and others. The gains indicate early momentum and potential volatility for the trading day, according to the market activity.
1 min readNEPHROS INC (NEPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202 nephros.com Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026 Record Second-Quarter Net Revenue Growth of 36% to $6 million; Core Program
6 min readNephros, Inc. announced it will file its first-quarter 2026 financial results on Thursday, May 7, 2026, after market close and will host a conference call the same day at 4:30 PM ET. The company, a water technology provider, detailed the dial-in information for the conference call and replay access. An audio archive will be available on the Nephros Investor Relations page.
2 min readNephros, Inc. has expanded its water safety support capabilities with the ASSE 12080 Legionella Water Safety and Management Specialist Certification earned by Brianne McGuire. This allows Nephros to offer consultative support and Water Management Program development services to healthcare facilities and other complex buildings. The company believes this new offering will provide additional value to customers, strengthen its overall value proposition, and open a new revenue stream through chargeable consulting services.
2 min readThird-Quarter Net Revenue of $4.8 million; Robust Growth Drives 35% Increase in Net Revenue and Fourth Consecutive Quarter of Profitability
2 min readSOUTH ORANGE, N.J., Oct. 30, 2025 ( GLOBE NEWSWIRE ) -- Nephros, Inc. ( NASDAQ:NEPH ) , a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Thursday, November 6, 2025 ...
2 min readSOUTH ORANGE, N.J., July 31, 2025 ( GLOBE NEWSWIRE ) -- Nephros, Inc. NEPH, a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Thursday, August 07, 2025 after market ...
2 min read
